Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
62.5M
-
Shares change
-
+10.3M
-
Total reported value, excl. options
-
$2.04B
-
Value change
-
+$339M
-
Put/Call ratio
-
0.23
-
Number of buys
-
108
-
Number of sells
-
-66
-
Price
-
$32.66
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q4 2020
212 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q4 2020.
Kura Oncology, Inc. - Common Stock (KURA) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.5M shares
of 87.5M outstanding shares and own 71.45% of the company stock.
Largest 10 shareholders include FMR LLC (9.12M shares), BlackRock Inc. (4.93M shares), Avoro Capital Advisors LLC (4M shares), VANGUARD GROUP INC (3.23M shares), CITADEL ADVISORS LLC (3.07M shares), STATE STREET CORP (2.68M shares), Foresite Capital Management IV, LLC (1.81M shares), EcoR1 Capital, LLC (1.77M shares), RTW INVESTMENTS, LP (1.7M shares), and Holocene Advisors, LP (1.62M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.